1. Home
  2. OLN vs INSP Comparison

OLN vs INSP Comparison

Compare OLN & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olin Corporation

OLN

Olin Corporation

N/A

Current Price

$14.88

Market Cap

2.5B

Sector

Industrials

ML Signal

N/A

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

N/A

Current Price

$68.85

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OLN
INSP
Founded
1892
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
OLN
INSP
Price
$14.88
$68.85
Analyst Decision
Hold
Hold
Analyst Count
15
18
Target Price
$20.20
★ $65.00
AVG Volume (30 Days)
★ 3.7M
863.2K
Earning Date
10-29-2026
11-02-2026
Dividend Yield
★ 5.13%
N/A
EPS Growth
N/A
★ 179.43
EPS
N/A
★ N/A
Revenue
★ $6,780,800,000.00
$82,050,000.00
Revenue This Year
$2.06
N/A
Revenue Next Year
$4.99
$3.91
P/E Ratio
N/A
★ N/A
Revenue Growth
3.68
★ 62.18
52 Week Low
$14.95
$38.91
52 Week High
$30.46
$147.03

Technical Indicators

Market Signals
Indicator
OLN
INSP
Relative Strength Index (RSI) 30.13 52.26
Support Level $14.95 $68.13
Resistance Level $24.81 $75.31
Average True Range (ATR) 0.60 3.25
MACD -0.00 -0.88
Stochastic Oscillator 1.56 31.75

Price Performance

Historical Comparison
OLN
INSP

About OLN Olin Corporation

Olin was founded in 1892 and has been publicly listed since 1917. The company has a unique dual identity compared with some of its chemical peers: it is the world's largest chlor-alkali producer by capacity, and it owns the Winchester brand, a leading US ammunition manufacturer. Olin has three reportable segments: chlor-alkali products and vinyls (CAPV or CAP), Epoxies, and Winchester, which represent around 55%, 20%, and 25% of sales, respectively.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

Share on Social Networks: